These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6839301)

  • 1. The relationship between family history, exposure to exogenous hormones, and estrogen receptor protein in breast cancer.
    Osborne MP; Rosen PP; Lesser ML; Schwartz MK; Menendez-Botet CJ; Fishman JH; Kinne DW; Beattie EJ
    Cancer; 1983 Jun; 51(11):2134-8. PubMed ID: 6839301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen and progesterone receptors in breast carcinoma: correlations with epidemiology and pathology.
    Lesser ML; Rosen PP; Senie RT; Duthie K; Menendez-Botet C; Schwartz MK
    Cancer; 1981 Jul; 48(2):299-309. PubMed ID: 7237401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex hormones and cardiovascular risk.
    La Vecchia C
    Hum Reprod; 1992 Feb; 7(2):162-7. PubMed ID: 1577926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast cancer in young women and use of oral contraceptives: possible modifying effect of formulation and age at use.
    Pike MC; Henderson BE; Krailo MD; Duke A; Roy S
    Lancet; 1983 Oct; 2(8356):926-30. PubMed ID: 6138501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A relationship between artifical menopause, previous estrogen consumption, and estrogen receptor content of breast neoplasms: preliminary communication.
    Wallace RB; Sherman BM; Bean JA
    Oncology; 1980; 37(2):111-3. PubMed ID: 7360478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Family history, oral contraceptive usage, and breast cancer.
    Black MM; Barclay TH; Polednak A; Kwon CS; Leis HP; Pilnik S
    Cancer; 1983 Jun; 51(11):2147-51. PubMed ID: 6839302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early oral contraceptive use as a prognostic factor in breast cancer.
    Olsson H; Möller TR; Ranstam J; Borg A; Fernö M
    Anticancer Res; 1988; 8(1):29-32. PubMed ID: 3358638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review: oral contraceptives and menopausal estrogens in relation to breast neoplasia.
    Brzezinski A; Schenker JG
    Isr J Med Sci; 1982 Apr; 18(4):433-8. PubMed ID: 7045033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer risk: effects of estrogen replacement therapy and body mass.
    Harris RE; Namboodiri KK; Wynder EL
    J Natl Cancer Inst; 1992 Oct; 84(20):1575-82. PubMed ID: 1404451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Permanent alterations induced in plasma prolactin and estrogen receptor concentration in benign and malignant tissue of women who started oral contraceptive use at an early age.
    Olsson H; Lindahl B; Ranstam J; Borg A; Fernö M; Norgren A
    Anticancer Res; 1987; 7(4B):853-6. PubMed ID: 3674773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Family history and oral contraceptives: unique relationships in breast cancer patients.
    Black MM; Kwon CS; Leis HP; Barclay TH
    Cancer; 1980 Dec; 46(12):2747-51. PubMed ID: 7448714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between estrogen receptors and weight in women with breast cancer.
    Papatestas AE; Panveliwalla D; Pertsemlidis D; Mulvihill M; Aufses AH
    J Surg Oncol; 1980; 13(2):177-80. PubMed ID: 7359923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex steroid hormones and breast cancer: is there a link with oral contraceptives and hormone replacement therapy?
    Khoo SK; Chick P
    Med J Aust; 1992 Jan; 156(2):124-32. PubMed ID: 1736053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exogenous progestins and breast cancer.
    Stanford JL; Thomas DB
    Epidemiol Rev; 1993; 15(1):98-107. PubMed ID: 8405216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of oral contraceptives and estrogen replacement therapy on the risk of rheumatoid arthritis: a population based study.
    Doran MF; Crowson CS; O'Fallon WM; Gabriel SE
    J Rheumatol; 2004 Feb; 31(2):207-13. PubMed ID: 14760786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiologic aspects of exogenous progestagens in relation to their role in pathogenesis of human breast cancer.
    van Leeuwen FE
    Acta Endocrinol (Copenh); 1991; 125 Suppl 1():13-26. PubMed ID: 1801500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral contraceptives and breast cancer.
    Brinton LA; Hoover R; Szklo M; Fraumeni JF
    Int J Epidemiol; 1982 Dec; 11(4):316-22. PubMed ID: 7152784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of teenage oral contraceptive use in a population-based series of early-onset breast cancer cases who have undergone BRCA mutation testing.
    Jernström H; Loman N; Johannsson OT; Borg A; Olsson H
    Eur J Cancer; 2005 Oct; 41(15):2312-20. PubMed ID: 16118051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen receptor protein of breast cancer as a predictor of recurrence.
    Butler JA; Bretsky S; Menendez-Botet C; Kinne DW
    Cancer; 1985 Mar; 55(6):1178-81. PubMed ID: 3971291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.